D. E. Shaw & Co., Inc. Hutchmed (China) LTD Call Options Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HCM
# of Institutions
69Shares Held
14MCall Options Held
2.7KPut Options Held
3.7K-
General Atlantic LLC New York, NY4MShares$68.9 Million1.57% of portfolio
-
Schroder Investment Management Group London, X03.85MShares$66.3 Million0.08% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1.57MShares$27 Million0.04% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.15MShares$19.9 Million0.3% of portfolio
-
Acadian Asset Management LLC Boston, MA487KShares$8.38 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.98B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...